Found: 5
Select item for more details and to access through your institution.
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 10, p. 1053, doi. 10.3390/ph14101053
- By:
- Publication type:
- Article
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 3, p. 200, doi. 10.3390/ph14030200
- By:
- Publication type:
- Article
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 299, doi. 10.3390/biomedicines10020299
- By:
- Publication type:
- Article
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02840-9
- By:
- Publication type:
- Article